Cargando…

Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer

Detalles Bibliográficos
Autores principales:	Carlsten, Mattias, Bryceson, Yenan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442339/ https://www.ncbi.nlm.nih.gov/pubmed/37604878 http://dx.doi.org/10.1038/s41392-023-01550-0

Ejemplares similares

LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity
por: Leijonhufvud, Caroline, et al.
Publicado: (2021)

Caspase-7 and acid sphingomyelinase: partner repairmans of gasdermin and perforin pores
por: Jin, Ke, et al.
Publicado: (2022)

Epigenetic regulation of NK cell differentiation and effector functions
por: Cichocki, Frank, et al.
Publicado: (2013)

Human NK cells, their receptors and function [Image: see text]
por: Quatrini, Linda, et al.
Publicado: (2021)

Editorial: Molecular and Cellular Pathways in NK Cell Development
por: Sitnicka, Ewa, et al.
Publicado: (2020)

NK cell dysfunction in patients with COVID-19
por: Bi, Jiacheng
Publicado: (2022)

NK cell dysfunction in severe COVID-19: TGF-β-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity
por: Barros-Martins, Joana, et al.
Publicado: (2022)

Transcriptomic perspectives of memory-like NK cells and aging
por: Wang, Dandan, et al.
Publicado: (2022)

Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
por: Ullrich, Evelyn, et al.
Publicado: (2022)

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
por: Carlsten, Mattias, et al.
Publicado: (2019)

Supramolecular attack particle: the way cytotoxic T lymphocytes kill target cells
por: Liu, Jiaqi, et al.
Publicado: (2020)

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells
por: Bryceson, Yenan T., et al.
Publicado: (2005)

Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
por: Carlsten, Mattias, et al.
Publicado: (2015)

Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G
por: Rajagopalan, Sumati, et al.
Publicado: (2006)

“Moonlighting” at the power plant: how mitochondria facilitate serial killing by CD8(+) cytotoxic T cells
por: Mougiakakos, Dimitrios, et al.
Publicado: (2021)

Spiking the MERS-coronavirus receptor
por: Bosch, Berend Jan, et al.
Publicado: (2013)

Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection
por: Kalra, Rajkumar Singh, et al.
Publicado: (2021)

NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development
por: Jelenčić, Vedrana, et al.
Publicado: (2018)

Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function
por: Pace, Matthew, et al.
Publicado: (2016)

AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
por: Wu, Jingjing, et al.
Publicado: (2015)

The SARS-CoV-2 spike protein: balancing stability and infectivity
por: Berger, Imre, et al.
Publicado: (2020)

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

ARID5B regulates metabolic programming in human adaptive NK cells
por: Cichocki, Frank, et al.
Publicado: (2018)

NK cells specifically TCR-dressed to kill cancer cells
por: Mensali, Nadia, et al.
Publicado: (2019)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

Can cannibalizing cancer cells challenge classic cell death classification?
por: Walton, Emma Louise
Publicado: (2017)

SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
por: Pierri, Ciro Leonardo
Publicado: (2020)

Targeting multiple epitopes on the spike protein: a new hope for COVID-19 antibody therapy
por: Sun, Yeping, et al.
Publicado: (2020)

SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
por: Xu, Shujing, et al.
Publicado: (2022)

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

Identification of Novel Functional Inhibitors of Acid Sphingomyelinase
por: Kornhuber, Johannes, et al.
Publicado: (2011)

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
por: Wang, Dong, et al.
Publicado: (2017)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies
por: Yang, Yang, et al.
Publicado: (2021)

Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
por: Kurniawan, Henry, et al.
Publicado: (2020)

Innate lymphoid cells and cancer: Role in tumor progression and inhibition
por: Yuan, Xiaodong, et al.
Publicado: (2021)

Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants
por: Ou, Junxian, et al.
Publicado: (2022)

Tumour travel tours – Why circulating cancer cells value company
por: Häfner, Sophia Julia
Publicado: (2020)

Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity
por: Lopes, Noëlla, et al.
Publicado: (2020)

Molecular Mechanisms Regulating Cytotoxic Lymphocyte Development and Function, and Their Associations to Human Diseases
por: Krzewski, Konrad, et al.
Publicado: (2014)

Neuroinflammation Associated With Inborn Errors of Immunity
por: Lindahl, Hannes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q6g43gr3t3pcmfo6o6kntvvuts